NPR Article: Wider Use Of Osteoporosis Drug Could Prevent Bone Fractures In More Elderly Women »

| NOF in the News, Osteoporosis in the News

In response to a recent NPR article detailing the positive results of a common osteoporosis drug, Elizabeth Thompson, NOF, CEO, said:  “When the experts in the field say that this study is “extremely important”, “highly effective”, and “a breakthrough”, we are making progress! Reducing suffering and maintaining life quality is important for our senior population—key… Read more »

NOF Named an Official Charity Partner of the TCS New York City Marathon and Fields a Team of Runners Aged 40+ »

| NOF in the News, Osteoporosis in the News, Press Releases

The National Osteoporosis Foundation (NOF), the leading bone health organization in the U.S., was named an Official Charity Partner of the 2018 TCS New York City Marathon. The race will take place on Sunday, November 4, 2018. For its inaugural team, NOF has secured five women over the age of 40 to join its Be… Read more »

Leading Organizations Meet To Discuss Unmet Needs In Osteoporosis and Outline An Initial Action Plan »

| NOF in the News, Osteoporosis in the News, Press Releases

June 11, 2018| Press Releases On June 11, 2018, leaders from the National Osteoporosis Foundation (NOF), International Osteoporosis Foundation (IOF), and Amgen’s Bone Health and Advocacy Relations teams convened in London, England at the Royal Academy of Medicine. The purpose of the meeting was to develop a concrete plan for a meaningful collaboration between the two organizations. Back row:… Read more »

NOF Statement on New Treatment Option for Glucocorticoid-Induced Osteoporosis (GIOP) »

| NOF in the News, Osteoporosis in the News

GIOP is the most common form of secondary osteoporosis. In the U.S., more than 10 percent of patients who receive long-term glucocorticoid treatment are diagnosed with a clinical fracture. The U.S. Food and Drug Administration (FDA) has recently approved the use of denosumab for the treatment of glucocorticoid-induced osteoporosis (GIOP) in men and women at… Read more »

NOF Response to JAMA Article Published December 26, 2017: The Association Between Calcium or Vitamin D Supplementation and Fracture Incidence in Community-Dwelling Older Adults: A Systematic Review and Meta-Analysis »

| NOF in the News, Osteoporosis in the News

Approximately 10 million Americans over the age of 50 have osteoporosis, a condition that causes bones to become weak and more likely to break[i]. In fact, two million bone breaks occur every year in the U.S. due to osteoporosis, often resulting in immobility, pain, placement in a nursing home, isolation and other health problems. Scientific… Read more »

Bone Index Ltd. Announces the American Medical Association Issues New Reimbursement Code for Bindex Osteoporosis Measurement »

| Osteoporosis in the News

Tuesday, January 2, 2018 – Bone Index Ltd., one of Europe’s top new manufacturers of medical devices, announces that the American Medical Association (AMA) has issued a new Category III CPT® code* for Bindex® measurement to help physicians in diagnosing osteoporosis. “In osteoporosis screening and diagnostics area, it has taken about 20 years since the… Read more »

NOF Response to USPSTF Recommendation on Calcium and Vitamin D »

| NOF in the News, Osteoporosis in the News

Comments Submitted to the USPSTF Draft Recommendation Statement on Vitamin D, Calcium, or Combined Supplementation for the Primary Prevention of Fractures in Adults: Preventive Medication The National Osteoporosis Foundation (NOF), the leading health organization solely dedicated to osteoporosis and bone health, appreciates the opportunity to provide comments on the latest USPSTF Draft Recommendation Statement on… Read more »